Polku Therapeutics
1 known investors
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.
Founders & leadership
S
SimonChief Executive Officer
S
SebastianChief Operating Officer
T
TimoScientific Co-founder
E
ErikScientific Co-founder